Ranitidine and Tarka drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Tarka (trandolapril; verapamil hydrochloride). Common drug interactions include amnesia among females and encephalopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Tarka. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Tarka?

Tarka has active ingredients of trandolapril; verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 2,409 Tarka users. Check the latest studies of Tarka.



On Jul, 31, 2026

18 people who take Ranitidine and Tarka together, and have interactions are studied.

Ranitidine and Tarka drug interactions.

What are the common drug interactions of Ranitidine and Tarka, by gender? *:

female:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Anxiety
  3. Bipolar disorder (mood disorder)
  4. Cholecystitis (infection of gallbladder)
  5. Loss of consciousness
  6. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  7. Nodal arrhythmia (an irregular heart beat originating from within the atrioventricular node)
  8. Suicide attempt
  9. Atrioventricular block complete (heart block complete)
  10. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

male:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Pancreatitis acute (sudden inflammation of pancreas)
  3. Gait disturbance
  4. Hyperhidrosis (abnormally increased sweating)
  5. Hypersensitivity
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Hypotension (abnormally low blood pressure)
  8. Nausea (feeling of having an urge to vomit)
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  10. Post procedural complication

What are the common drug interactions of Ranitidine and Tarka, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Anxiety
  3. Bipolar disorder (mood disorder)
  4. Loss of consciousness
  5. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  6. Suicide attempt
  7. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  8. Type 2 diabetes mellitus

50-59:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  3. Fall
  4. Gait disturbance
  5. Hypoaesthesia (reduced sense of touch or sensation)
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Type 2 diabetes mellitus

60+:

  1. Cholecystitis (infection of gallbladder)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Epistaxis (bleed from the nose)
  4. Erythema (redness of the skin)
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypersensitivity
  7. Hypotension (abnormally low blood pressure)
  8. Nausea (feeling of having an urge to vomit)
  9. Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously)
  10. Post procedural complication

What are the existing conditions these people have? *

  1. Diabetes: 6 people, 33.33%
  2. Stress And Anxiety: 4 people, 22.22%
  3. Pain: 4 people, 22.22%
  4. Depression: 4 people, 22.22%
  5. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 11.11%
  6. Cough: 2 people, 11.11%
  7. Dizziness: 2 people, 11.11%
  8. Throat Irritation: 2 people, 11.11%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 11.11%
  10. Bipolar Disorder (mood disorder): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Tarka?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine and Tarka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tarka:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tarka and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine and trandolapril; verapamil hydrochloride (the active ingredients of Ranitidine and Tarka, respectively), and Ranitidine and Tarka (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: